KIMBERLY SANDERS: Open Payments
NPI 1760762405 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 12 payments from 6 companies in 2025. Trend: 2023 $30 · 2024 $79 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $153 |
| Neurocrine BioSciences, Inc. | 1 | $112 |
| Alkermes, Inc. | 1 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| ABBVIE INC. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: COBENFY, INGREZZA, LYBALVI, SPRAVATO, VRAYLAR, Auvelity.
Industry payments across OH — which companies pay providers there.
